Aquestive therapeutics announces fda clearance of investigational new drug application (ind) for aqst-109 epinephrine oral film

Warren, n.j., feb. 24, 2022 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst), a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, today announced the opening of its investigational new drug application (ind) from the u.s. food and drug administration (fda) for its drug candidate aqst-109 epinephrine oral film.
AQST Ratings Summary
AQST Quant Ranking